Clinical and microbiological impact of long-term discontinuation of fluoroquinolone prophylaxis in haematological patients with prolonged profound neutropenia

Eur J Haematol. 2021 Sep;107(3):377-379. doi: 10.1111/ejh.13670. Epub 2021 Jun 8.

Authors

Anke Verlinden^{1

2}, Wilfried A Schroyens^{1

2}, Alain P Gadisseur^{1

2}

Affiliations

¹ Department of Haematology, Antwerp University Hospital, Edegem, Belgium.
² Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium.

PMID: 34018235
DOI: 10.1111/ejh.13670

No abstract available

Keywords: antimicrobial prophylaxis; antimicrobial resistance; febrile neutropenia; fluoroquinolone.

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents / administration & dosage*
Antibiotic Prophylaxis / methods*
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Bacterial Infections / drug therapy*
Bacterial Infections / microbiology
Bacterial Infections / pathology
Drug Administration Schedule
Febrile Neutropenia / drug therapy*
Febrile Neutropenia / microbiology
Febrile Neutropenia / pathology
Female
Fluoroquinolones / administration & dosage*
Hematopoietic Stem Cell Transplantation / methods
Humans
Leukemia / microbiology
Leukemia / pathology
Leukemia / therapy
Lymphoma / microbiology
Lymphoma / pathology
Lymphoma / therapy
Male
Middle Aged
Multiple Myeloma / microbiology
Multiple Myeloma / pathology
Multiple Myeloma / therapy
Myelodysplastic Syndromes / microbiology
Myelodysplastic Syndromes / pathology
Myelodysplastic Syndromes / therapy
Prospective Studies

Substances

Anti-Bacterial Agents
Antineoplastic Agents
Fluoroquinolones